D.E. Shaw & Co
EXAS

D.E. Shaw & Co’s Exact Sciences EXAS Stock Holding History

D.E. Shaw & Co’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,600
Closed -$450K – 4524
2024
Q3 		$450K Sell
6,600
-56,200
-89% -$3.17M ﹤0.01% 3762
2024
Q2 		$2.65M Buy
+62,800
New +$3.46M ﹤0.01% 2385
2024
Q1 		– Sell
-10,000
Closed -$740K – 4444
2023
Q4 		$740K Hold
10,000
– – ﹤0.01% 3327
2023
Q3 		$682K Hold
10,000
– – ﹤0.01% 3295
2023
Q2 		$939K Hold
10,000
– – ﹤0.01% 3128
2023
Q1 		$678K Sell
10,000
-20,000
-67% -$1.29M ﹤0.01% 3394
2022
Q4 		$1.49M Hold
30,000
– – ﹤0.01% 3168
2022
Q3 		$975K Sell
30,000
-3,600
-11% -$148K ﹤0.01% 3615
2022
Q2 		$1.32M Sell
33,600
-100,200
-75% -$5.36M ﹤0.01% 3430
2022
Q1 		$9.36M Buy
133,800
+113,800
+569% +$8.32M 0.01% 1648
2021
Q4 		$1.56M Hold
20,000
– – ﹤0.01% 3576
2021
Q3 		$1.91M Buy
20,000
+10,000
+100% +$1.06M ﹤0.01% 3075
2021
Q2 		$1.24M Buy
+10,000
New +$1.19M ﹤0.01% 3362
2021
Q1 		– Sell
-21,300
Closed -$2.82M – 4171
2020
Q4 		$2.82M Sell
21,300
-9,800
-32% -$1.19M ﹤0.01% 2319
2020
Q3 		$3.17M Sell
31,100
-4,100
-12% -$354K ﹤0.01% 2029
2020
Q2 		$3.06M Buy
35,200
+13,900
+65% +$1.11M ﹤0.01% 2068
2020
Q1 		$1.24M Sell
21,300
-50,300
-70% -$4.08M ﹤0.01% 2573
2019
Q4 		$6.62M Sell
71,600
-10,600
-13% -$932K 0.01% 1512
2019
Q3 		$7.43M Sell
82,200
-9,900
-11% -$1.13M 0.01% 1368
2019
Q2 		$10.9M Buy
92,100
+20,000
+28% +$2.02M 0.01% 1087
2019
Q1 		$6.25M Sell
72,100
-67,900
-49% -$5.78M 0.01% 1400
2018
Q4 		$8.83M Buy
140,000
+10,400
+8% +$714K 0.01% 1175
2018
Q3 		$10.2M Buy
129,600
+25,000
+24% +$1.63M 0.01% 1111
2018
Q2 		$6.25M Buy
104,600
+5,000
+5% +$269K 0.01% 1371
2018
Q1 		$4.02M Sell
99,600
-60,400
-38% -$2.95M 0.01% 1555
2017
Q4 		$8.41M Buy
160,000
+27,900
+21% +$1.49M 0.01% 1132
2017
Q3 		$6.22M Sell
132,100
-17,700
-12% -$712K 0.01% 1219
2017
Q2 		$5.3M Buy
149,800
+79,400
+113% +$2.45M 0.01% 1294
2017
Q1 		$1.66M Buy
70,400
+30,000
+74% +$594K ﹤0.01% 1955
2016
Q4 		$540K Sell
40,400
-16,700
-29% -$270K ﹤0.01% 2803
2016
Q3 		$1.06M Buy
+57,100
New +$1.01M ﹤0.01% 2349
2015
Q1 		– Sell
-12,100
Closed -$332K – 3727
2014
Q4 		$332K Hold
12,100
– – ﹤0.01% 3593
2014
Q3 		$234K Buy
+12,100
New +$222K ﹤0.01% 3814

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

D.E. Shaw & Co's EXAS Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 502,142 shares — an estimated $51M sold.

D.E. Shaw & Co first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $216M in Q1 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 502,142 Exact Sciences shares in Q1 2026, an estimated $51M.
  • D.E. Shaw & Co first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • D.E. Shaw & Co's Exact Sciences position peaked at $216M in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.